All outreach archives All outreach archives Use the below filters to find publications by type, issue area, and scholar. Filter listing Apply filters Regulatory Comments Behavioral Health, Federal Government Affairs, Harm Reduction, Healthier Communities, Substance Regulation, Tobacco Harm Reduction R Street Comments on the Proposed FDA/CTP Flavor Guidance Jeffrey S. Smith May 7, 2026 Testimony Behavioral Health, Harm Reduction, Healthier Communities, Northeast, Opioid Harm Reduction, State Policy, Thriving Families R Street Testimony for the VA Senate Rehabilitation and Social Services Committee in Support of VA HB 283, Removing penalties from prenatal use of MOUDs Robert Melvin March 6, 2026 Testimony Behavioral Health, Harm Reduction, Healthier Communities, Northeast, Opioid Harm Reduction, State Policy R Street Testimony in Support of MD SB 562, pharmacist prescribing of MOUD Stacey McKenna March 3, 2026 Coalition Letters, Congressional Letters, Letters Behavioral Health, Federal Government Affairs, Harm Reduction, Healthier Communities, Opioid Harm Reduction R Street and Drug Policy Alliance Coalition Letter Regarding Xylazine and Nitazene Scheduling Stacey McKenna March 2, 2026 Testimony Behavioral Health, Harm Reduction, Healthier Communities, Northeast, Opioid Harm Reduction, State Policy R Street Testimony in Support of VA SB 421, Remote Pharmacy Dispensing at OTPs Stacey McKenna Feb 19, 2026 Testimony Behavioral Health, Harm Reduction, Healthier Communities, Opioid Harm Reduction, South, State Policy Testimony in Support of Tennessee SB 1848, to Reduce Barriers to Buprenorphine Treatment for Opioid Use Disorder Stacey McKenna Feb 18, 2026 Testimony Behavioral Health, Harm Reduction, Healthier Communities, Northeast, Opioid Harm Reduction, State Policy, Thriving Families R Street Testimony in Support of VA HB 283, Removing penalties from prenatal use of MOUDs Robert Melvin Feb 5, 2026 Testimony Behavioral Health, Harm Reduction, Healthier Communities, Northeast, Opioid Harm Reduction, State Policy R Street Testimony in Support of VA SB 421, Remote Pharmacy Dispensing at OTPs Stacey McKenna Jan 30, 2026
Regulatory Comments Behavioral Health, Federal Government Affairs, Harm Reduction, Healthier Communities, Substance Regulation, Tobacco Harm Reduction R Street Comments on the Proposed FDA/CTP Flavor Guidance Jeffrey S. Smith May 7, 2026
Testimony Behavioral Health, Harm Reduction, Healthier Communities, Northeast, Opioid Harm Reduction, State Policy, Thriving Families R Street Testimony for the VA Senate Rehabilitation and Social Services Committee in Support of VA HB 283, Removing penalties from prenatal use of MOUDs Robert Melvin March 6, 2026
Testimony Behavioral Health, Harm Reduction, Healthier Communities, Northeast, Opioid Harm Reduction, State Policy R Street Testimony in Support of MD SB 562, pharmacist prescribing of MOUD Stacey McKenna March 3, 2026
Coalition Letters, Congressional Letters, Letters Behavioral Health, Federal Government Affairs, Harm Reduction, Healthier Communities, Opioid Harm Reduction R Street and Drug Policy Alliance Coalition Letter Regarding Xylazine and Nitazene Scheduling Stacey McKenna March 2, 2026
Testimony Behavioral Health, Harm Reduction, Healthier Communities, Northeast, Opioid Harm Reduction, State Policy R Street Testimony in Support of VA SB 421, Remote Pharmacy Dispensing at OTPs Stacey McKenna Feb 19, 2026
Testimony Behavioral Health, Harm Reduction, Healthier Communities, Opioid Harm Reduction, South, State Policy Testimony in Support of Tennessee SB 1848, to Reduce Barriers to Buprenorphine Treatment for Opioid Use Disorder Stacey McKenna Feb 18, 2026
Testimony Behavioral Health, Harm Reduction, Healthier Communities, Northeast, Opioid Harm Reduction, State Policy, Thriving Families R Street Testimony in Support of VA HB 283, Removing penalties from prenatal use of MOUDs Robert Melvin Feb 5, 2026
Testimony Behavioral Health, Harm Reduction, Healthier Communities, Northeast, Opioid Harm Reduction, State Policy R Street Testimony in Support of VA SB 421, Remote Pharmacy Dispensing at OTPs Stacey McKenna Jan 30, 2026
